One2Treat’s Post

🌟 SABCS 2024 Poster Highlight Prof Dr Marc Buyse and Dr Samuel Salvaggio, PhD introduce a new statistical method to evaluate the benefit/risk ratio of TCH vs AC-TH in HER2-positive early breast cancer. Findings reveal TCH's significant cardiac safety advantage, supporting the move away from anthracyclines. Discover these impactful updates.👇 For all SABCS 2024 videos, find the link in the comments! #MediMix #SABCS2024 #HER2Positive #BreastCancer

In October We Wear Pink: Breast Cancer Screening Guidelines Our experts will discuss the updated guidelines on breast cancer screening as well as imaging choice considerations and what constitutes average risk for screening parameters. Throughout the discussion, we will be conducting interactive board-style questions to get you #APEAprepared for the certification exam. Sign up today! https://hubs.la/Q02R00dB0 #nursepractitioner #advancedpractice #advancedmedicine #primarycare #nplife #futurenp #npstudent

Today we observe #NationalMammographyDay, a critical moment to emphasize the importance of early breast cancer detection. At #JIPO, our focus on cutting-edge research underscores the vital role of mammography in saving lives https://loom.ly/1YB46rw #mammography #breastcancer

In this latest episode of #OncLiveOnAir 🎙️, Stacey A. Cohen, MD, of Fred Hutch, discusses 🗣️ the evolving role of circulating tumor DNA in clinical decision-making for patients with colorectal cancer, particularly through findings from the CIRCULATE-Japan GALAXY trial. Tune in now 🎧 👉 : https://lnkd.in/eGcjWJ7d

Excited to share our latest publication in #npjBreastCancer! 🎉 In this GIM study, we investigated clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in HER2-positive metastatic breast cancer. Our findings highlight key factors, such as HER2 IHC 3+ expression, non-visceral metastases, and limited metastatic sites, that are associated with higher chances of achieving a durable response. Many thanks to @Linda Cucciniello and the other co-authors from the GIM group for their invaluable contributions to the success of this work 🔗 Read the full article here:  https://lnkd.in/d2CwnUV3  Lucia Del Mastro Eva Blondeaux Claudia Bighin Alessandra Fabi Filippo Montemurro Michelino De Laurentiis Lorenzo Gerratana Grazia Arpino #BreastCancer #HER2Positive #OncologyResearch #PersonalizedMedicine #Teamwork #GIM

Did you know? Breast cancer is when cells in the breast grow uncontrollably. It’s important to understand that there are different types, and early detection can save lives! Stay informed and check regularly. #PinkOctober #BreastCancerAwareness #KnowYourBreasts #EFFOutreach #EFFCares #HealthAwareness #EphraimAndFriendsFoundation #HandsHeartsSmile

A Rare Case of Bilateral Synchronous Male Breast Cancer: A Multimodality Approach   You can see the free full text of the research by Cihan Özgür et al   Link : https://lnkd.in/dWciYj47   #Breastcancer #breastultrasonography #magneticresonanceimaging #mammography #malebreastcancer #synchronousneoplasms

We know false positives can be frustrating, but PLEASE keep up with your mammograms. Know your breast density, advocate for appropriate screening, and know that early detection is the key to surviving breast cancer. SEE WHY - https://lnkd.in/gGqVg9kX #mydensitymatters #checkyourchart

🌟 Poster from SABCS 2024! Dr Elisa Agostinetto presents the phase II DECRESCENDO trial, exploring de-escalation of chemotherapy in HER2+/HR-, node-negative early breast cancer. Interim results show an impressive pCR rate of 86%, with the potential to reduce treatment toxicity while maintaining excellent outcomes. Discover these impactful updates.👇 For all SABCS 2024 videos, find the link in the comments! #MediMix #SABCS2024 #HER2Positive #BreastCancerResearch

We are proud to share insights from our partner, cCARE's Casandra Anderson, MD, on the important topic of dense breast tissue and its link to breast cancer risk. Did you know that having dense breast tissue can increase your risk of developing breast cancer? Dr. Anderson, Breast Surgeon/Surgical Oncology at cCARE Fresno, emphasizes the importance early detection and choosing the right screening tools. If you have dense breast tissue, we encourage you to speak with your healthcare provider about the best screening options for you. Stay proactive and informed! 📺 Check out Dr. Anderson's interview with ABC30 to learn more: https://lnkd.in/ePvzdaER #BreastCancerAwareness #DenseBreastTissue #EarlyDetection #DrCasandraAnderson #cCARE #ProactiveHealth